Citation Impact
Citing Papers
Review article: the global emergence of Helicobacter pylori antibiotic resistance
2015
Activation of β-catenin by carcinogenic Helicobacter pylori
2005
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia-inducible factor-1α expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas
2006
Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
2015
Gastric cancer
2016 Standout
Astrocytes: biology and pathology
2009 Standout
Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer
2009
Colonic bacterial metabolites and human health
2013
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Angiogenesis in pre-malignant conditions
2009
Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer
2013
Microsatellite Instability in Colorectal Cancer
2010 Standout
Tumors are unique organs defined by abnormal signaling and context
2001
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Biology of colorectal cancer
2015
Ulcerative Colitis
2011 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
A New Modified Concomitant Therapy for Helicobacter pylori Eradication in Turkey
2011
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain
2016 StandoutNatureNobel
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Attempts to enhance the eradication rate ofHelicobacter pyloriinfection
2014
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy
2016
Systematic review with meta‐analysis: the efficacy of levofloxacin triple therapy as the first‐ or second‐line treatments of Helicobacter pylori infection
2016
A Comparative Study of Sequential Therapy and Standard Triple Therapy for Helicobacter pylori Infection: A Randomized Multicenter Trial
2014
Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target
2007 Nobel
Reprogramming Cellular Identity for Regenerative Medicine
2012
The combination of silencing BAG3 and inhibition of the JNK pathway enhances hyperthermia sensitivity in human oral squamous cell carcinoma cells
2013
Eradication of gastric cancer is now both possible and practical
2013
Endotoxemia and gut barrier dysfunction in alcoholic liver disease†
2009
Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis
2015
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
High Level of Antimicrobial Resistance in French Helicobacter pylori Isolates
2010
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial
2011
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
2015
Inflammation and Colon Cancer
2010 Standout
Pouchitis: What Every Gastroenterologist Needs to Know
2013
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
The immune system in atherosclerosis
2011 Standout
The role of the gut microbiota in NAFLD
2016
Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin‐Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin‐Resistant Strains
2012
Immunity, Inflammation, and Cancer
2010 Standout
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
2013
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
2011
Accuracy of GastroPanel for the diagnosis of atrophic gastritis
2014
Helicobacter pyloritherapy: Present and future
2012
Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
2013
Neuroplasticity and dysfunction after gastrointestinal inflammation
2014
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
EMT: 2016
2016 Standout
Ulcerative colitis
2016 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Assessment of Sequential and Standard Triple Therapy in Treatment of Helicobacter pylori Infection in Children Dependent on Bacteria Sensitivity to Antibiotics
2016
Influence of diet on the gut microbiome and implications for human health
2017 Standout
Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease
2011
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
2009 Standout
Gastric cancer
2020 Standout
Pouchitis and Pouch Dysfunction
2009
Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in First-Degree Relatives of Gastric Cancer Patients Compared with Age-Sex Matched Controls
2013
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Optimizing clarithromycin-containing therapy forHelicobacter pyloriin the era of antibiotic resistance
2014
Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance
2013
STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice
2008
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
2012
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions
2010
Neuro-Immune Interactions at Barrier Surfaces
2016
Gold-nanorods-siRNA nanoplex for improved photothermal therapy by gene silencing
2015
DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer
2014
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
NF-κB functions as a tumour promoter in inflammation-associated cancer
2004 StandoutNature
Inflammation and cancer: how friendly is the relationship for cancer patients?
2009
The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use
2015
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial
2012
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Using sulfuramidimidoyl fluorides that undergo sulfur(vi) fluoride exchange for inverse drug discovery
2020 StandoutNobel
Standard triple and sequential therapies for Helicobacter pylori eradication: An update
2012
H. pylori Infection Is a Key Risk Factor for Proximal Gastric Cancer
2010
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Helicobacter pylori and gastrointestinal tract adenocarcinomas
2002
Value of gastrin-17 in detecting antral atrophy
2011
Modeling Development and Disease with Organoids
2016 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
The human microbiome: at the interface of health and disease
2012 Standout
Intestinal microbiota in functional bowel disorders: a Rome foundation report
2012
Ten‐day sequential versus triple therapy for H elicobacter pylori eradication: A prospective, open‐label, randomized trial
2012
Irritable Bowel Syndrome
2015 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach
2016
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
2014
Comparison of Hybrid and Sequential Therapies for H elicobacter pylori Eradication in I ran: A Prospective Randomized Trial
2012
High antibiotic resistance of Helicobacter pylori and its effect on tailored and empiric eradication of the organism in Lower Silesia, Poland
2016
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Implications of antioxidant enzymes in human gastric neoplasms
2009
Antibiotic resistance of Helicobacter pylori in Mashhad, Iran.
2013
Prevalence of Primary and Secondary Antimicrobial Resistance of H elicobacter pylori in K orea from 2003 through 2012
2012
Meta-Analysis of Sequential, Concomitant and Hybrid Therapy for <i>Helicobacter pylori</i> Eradication
2015
Lipotoxicity and the gut-liver axis in NASH pathogenesis
2017
Primary antibiotic resistance ofHelicobacter pyloristrains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study
2015
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Clinical Evaluation of a Ten‐Day Regimen with E someprazole, M etronidazole, A moxicillin, and C larithromycin for the Eradication of H elicobacter pylori in a High Clarithromycin Resistance Area
2013
Sitafloxacin Activity against Helicobacter pylori Isolates, Including Those with gyrA Mutations
2009
Evolution of H elicobacter pylori susceptibility to antibiotics during a 10‐year period in L ithuania
2012
Helicobacter pylori Eradication Rates in Children Upon Susceptibility Testing Based on Noninvasive Stool Polymerase Chain Reaction Versus Gastric Tissue Culture
2011
Alcohol and Gut-Derived Inflammation
2017
Relative Quantification of Proteins in Human Cerebrospinal Fluids by MS/MS Using 6-Plex Isobaric Tags
2008
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Mediterranean Diet and Health: Food Effects on Gut Microbiota and Disease Control
2014
Works of Alba Rocco being referenced
Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy
2005
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial
2010
CD133 and CD44 Cell surface markers do not identify cancer stem cells in primary human gastric tumors
2011
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression
2006
Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis
2011
Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial‐derived S100B protein
2009
Probiotics
2004
Diet,H pyloriinfection and gastric cancer: Evidence and controversies
2007
Myenteric neuronal loss in rats with experimental colitis: Role of tissue transglutaminase-induced apoptosis
2008
Alcoholic disease: Liver and beyond
2014
Is there a link between environmental factors and a genetic predisposition to cancer? A lesson from a familial cluster of gastric cancers
2003
Expression of COX‐2, mPGE‐synthase 1 , MDR‐1 (P‐gp), and Bcl‐x L : a molecular pathway of H pylori ‐related gastric carcinogenesis
2004
<i>Helicobacter pylori</i> and Epigenetic Mechanisms Underlying Gastric Carcinogenesis
2007
Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease
2012
Helicobacter pylori and molecular events in precancerous gastric lesions
2004
Effects of long-term PPI treatment on producing bowel symptoms and SIBO
2010
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection
2012
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates
2008
BAG3 protein delocalisation in prostate carcinoma
2010
Enteric Glial-Derived S100B Protein Stimulates Nitric Oxide Production in Celiac Disease
2007
Effect of Helicobacter pyloriinfection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis
1999
Vascular endothelial growth factor and neo‐angiogenesis in H. pylori gastritis in humans
2005
Chemoprevention of Gastric Cancer: Role of COX-2 Inhibitors and Other Agents
2004
Vascular Endothelial Growth Factor and Cyclooxygenase-2 are Overexpressed in Ileal Pouch-Anal Anastomosis
2006
In Vivo and In Vitro Studies of Cytosolic Phospholipase A2Expression inHelicobacter pyloriInfection
2001
The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease
2016
Protective effects ofLactobacillus paracaseiF19 in a rat model of oxidative and metabolic hepatic injury
2010
Loss of Beta-Catenin Expression in Metastatic Gastric Cancer
2003
Risk factors in gastric cancer.
2010